Table 2 Patient characteristics at the lowest and highest BMI-SDS
From: Assessment of the renal function of patients with anorexia nervosa
Parameter | n | Median (min–max) or n (%) | p-value | |
|---|---|---|---|---|
BMI-SDS (min) | BMI-SDS (max) | |||
Duration of therapy (days) | 34 | 19 (0–3878) | 277 (0–1710) | 0.073 |
BMI-SDS | 34 | − 3.59 (− 8.81– − 0.41) | − 0.39 (− 5.12–1.63) | < 0.001** |
Degree of obesity | 34 | − 30.8 (− 50.6– − 4.52) | − 5.8 (− 38.4–29.7) | < 0.001** |
Type of AN | 34 | 32 (94.1) | 32 (94.1) | – |
BT (℃) | 1 | 36.6 | 36.3 | – |
HR (bpm) | 25 | 60 (41–82) | 75 (54–112) | < 0.001 |
SBP (mmHg) | 21 | 85 (72–118) | 104 (87–124) | < 0.001 |
DBP (mmHg) | 21 | 53 (43–77) | 62 (46–80) | 0.024 |
Alb (g/dL) | 27 | 4.7 (3.9–5.4) | 4.6 (3.8–5.3) | 0.11 |
Pre-Alb (mg/dL) | 18 | 23 (13–36) | 29 (20–40) | 0.007** |
Cr-eGFR (mL/min/1.73 m2) | 34 | 84.2 (59.9–130.5) | 108.5 (72.4–182.8) | < 0.001** |
Na (mEq/L) | 32 | 139 (135–147) | 140 (136–142) | 0.18 |
K (mEq/L) | 32 | 4.3 (3.0–4.7) | 4.1 (3.7–5.1) | 0.73 |
Cl (mEq/L) | 32 | 105 (90–111) | 105 (103–108) | 0.24 |
Ht (%) | 34 | 40.4 (33.9–45.4) | 39 (26.5–45.7) | 0.096 |
UA (mg/dL) | 34 | 4.6 (3.5–10.1) | 4.4 (3.4–5.9) | 0.41 |
BUN (mg/dL) | 34 | 16.4 (9.7–42.7) | 13.3 (6.4–26.2) | < 0.001** |
Usg | 24 | 1.016 (1.002–1.039) | 1.011 (1.004–1.037) | 0.41 |
FT3 (pg/mL) | 4 | 1.16 (0.83–2.03) | 3.57 (2.50–4.06) | – |
FT4 (ng/dL) | 15 | 1.01 (0.63–1.44) | 1.15 (0.97–1.37) | 0.026* |
TSH (μU/mL) | 15 | 1.57 (0.09–3.81) | 1.39 (0.57–3.53) | 0.27 |
FSH (mIU/mL) | 8 | 1.00 (0.10–4.50) | 5.75 (0.30–9.90) | 0.022* |
E2 (pg/mL) | 8 | 11.2 (5.0–93.0) | 30.9 (5.0–167.0) | 0.11 |